![]() Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. | ![]() Protalix BioTherapeutics Protalix is a biopharmaceutical company focused on the development, production, and commercialization of recombinant therapeutic proteins. | ![]() Five Prime Therapeutics Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies. | |
Founding Date | Founding Date 1988 | Founding Date 1994 | Founding Date 2001 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Leiden, NL HQ Leiden, NL | Locations Karmiel, IL HQ | Locations South San Francisco, US HQ |
Employees | Employees 404 | Employees 213 | Employees 5141% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) $52.7m (FY, 2025) | Revenue (est.) $13.2m (FY, 2020) |
Cost of goods | Cost of goods $41.6m (FY, 2025) | Cost of goods $25.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $341m (FY, 2025) | Gross profit $27.2m (FY, 2025) | Gross profit N/A |
Net income | Net income $2.5m (FY, 2025) | Net income ($6.6m) (FY, 2025) | Net income ($84.3m) (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 62.5m | Total funding raised $ 237.2m |

Protalix is a biopharmaceutical company focused on the development, production, and commercialization of recombinant therapeutic proteins.
View company
Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies.
View company